The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 18, 2017
Filed:
Mar. 14, 2014
Applicant:
Bavarian Nordic A/s, Kvistgaard, DK;
Inventors:
Cédric Cheminay, Munich, DE;
Ariane Volkmann, Andechs, DE;
Paul Chaplin, Gafelfing, DE;
Mark Suter, Lucerne, CH;
Assignee:
BAVARIAN NORDIC A/S, Kvistgaard, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/285 (2006.01); A61K 39/12 (2006.01); A61K 39/165 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/285 (2013.01); A61K 39/12 (2013.01); A61K 39/165 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55 (2013.01); A61K 2039/70 (2013.01); C12N 2710/24034 (2013.01); C12N 2710/24043 (2013.01); C12N 2710/24134 (2013.01); C12N 2710/24143 (2013.01); C12N 2760/18434 (2013.01);
Abstract
The invention relates to compositions and methods for inducing a protective immune response against a poxvirus in a human neonate or infant of less than 6 months of age. The invention encompasses administering a single high dose of an MVA to a human neonate or infant of less than 6 months of age, wherein the administration induces protective T- and B-cell responses against a poxvirus in the human neonate or infant.